Literature DB >> 19330732

Seroprevalence of hepatitis B and C viruses in the province of Tokat in the Black Sea region of Turkey: A population-based study.

Beytullah Yildirim1, Sener Barut, Yunus Bulut, Gülgün Yenişehirli, Metin Ozdemir, Ilhan Cetin, Ilker Etikan, Ali Akbaş, Omer Atiş, Hüseyin Ozyurt, Semsettin Sahin.   

Abstract

BACKGROUND/AIMS: Viral hepatitides are considered a major health problem worldwide. There are only a few studies relevant to the epidemiology of these types of infection in the normal healthy population. In this study, we aimed to determine the seroprevalence of hepatitis B and hepatitis C as well as the frequency of isolated anti-HBc IgG positivity among a normal healthy population in a northern province of Turkey.
METHODS: This study was conducted in 70 areas (12 urban and 58 rural) in the province of Tokat, which is in the Black Sea region of Turkey, with about 530,000 inhabitants 18 years and older. All urban regions and some rural regions selected by a cluster sampling method were included in the study. The study population of 1,095 subjects (541 male and 554 female; urban 555 and rural 540) was selected by a random sampling method among 530,000 individuals. All individuals were tested for HBsAg, anti- HBs, anti-HBc IgG, anti-HCV, and alanine aminotransferase.
RESULTS: The mean age of all participants was 41.4+/-17 years (range, 18-95). HBsAg, anti-HBs, anti-HBc IgG only, isole and anti-HCV were detected in 60 (5.5%), 250 (22.8%), 132 (12.1%), and 23 (2.1%) individuals of the 1,095 total participants, respectively. We did not find statistically significant differences between hepatitis B and C markers for men versus women or those living in rural versus urban areas. The rate of HBsAg positivity in individuals with a history of marriage to close relatives was higher.
CONCLUSIONS: We found that the seroprevalences of hepatitis B and C in a northern province of Turkey are similar to the averages reported in other studies that were conducted in a different region of our country. The history of marriage to close relatives was associated with hepatitis B.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19330732

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  13 in total

Review 1.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 2.  Hepatitis C virus infection in the Middle East and North Africa "MENA" region: injecting drug users (IDUs) is an under-investigated population.

Authors:  S Ramia; N M Melhem; K Kreidieh
Journal:  Infection       Date:  2012-01-12       Impact factor: 3.553

3.  Frequency of HCV infection in renal cell carcinoma patients.

Authors:  Burçin Budakoğlu; Sercan Aksoy; Çağatay Arslan; Ümmügül Üyetürk; Nalan Akgül Babacan; Muhammet Fuat Özcan; Ramazan Yıldız; Başak Bala Öven; Nuriye Yıldırım Özdemir; Ömer Dizdar; Süleyman Büyükberber; M Bülent Akıncı; Ibrahim Türker; Berna Öksüzoğlu; Kadri Altundag; Nurullah Zengin
Journal:  Med Oncol       Date:  2011-04-03       Impact factor: 3.064

4.  Characterization of the Interleukin-28B Gene rs12979860 C/T Polymorphism in Turkish Chronic Hepatitis C Patients and Healthy Individuals.

Authors:  Serpil Taheri; Bilgehan Aygen; Keziban Korkmaz; Orhan Yıldız; Gökmen Zararsız; Halit Canatan
Journal:  Balkan Med J       Date:  2015-04-01       Impact factor: 2.021

5.  Protection Provided by Hepatitis B Vaccine in Adult Population of Chaharmahal and Bakhtiari Province, Iran in 2013.

Authors:  Masoumeh Moezzi; Reza Imani
Journal:  J Clin Diagn Res       Date:  2016-04-01

Review 6.  Systematic review and meta-analysis of HIV, HBV and HCV infection prevalence in Sudan.

Authors:  M M Badawi; M S Atif; Y Y Mustafa
Journal:  Virol J       Date:  2018-09-25       Impact factor: 4.099

Review 7.  Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review.

Authors:  Mehlika Toy; Fatih Oguz Önder; Tanja Wörmann; A Mithat Bozdayi; Solko W Schalm; Gerard J Borsboom; Joost van Rosmalen; Jan Hendrik Richardus; Cihan Yurdaydin
Journal:  BMC Infect Dis       Date:  2011-12-12       Impact factor: 3.090

8.  Impact of Interleukin 28B Genotype on the Virological Responses in Chronic Hepatitis C Treatment.

Authors:  Bilgehan Aygen; Orhan Yildiz; Sila Akhan; Ozgur Gunal; Serpil Taheri; Gokmen Zararsiz; Murat Sayan; Aydin Rustemoglu; Elif Sargin Altinok
Journal:  Gastroenterology Res       Date:  2014-12-27

9.  Eight-year seroprevalence of HBV, HCV and HIV in Diyarbakir training and research hospital.

Authors:  Mine Turhanoğlu; Arzu Onur; Fulya Bayındır Bilman; Zeynep Ayaydın; Gülseren Samancı Aktar
Journal:  Int J Med Sci       Date:  2013-09-12       Impact factor: 3.738

Review 10.  Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.

Authors:  Susan J M Hahné; Irene K Veldhuijzen; Lucas Wiessing; Tek-Ang Lim; Mika Salminen; Marita van de Laar
Journal:  BMC Infect Dis       Date:  2013-04-18       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.